News

A negative PET scan after two cycles of eBEACOPP allows treatment intensity to be reduced without affecting disease control

New trial shows a combination of ibrutinib and obinutuzumab is an alternative to ibrutinib plus chemo in first-line treatment of CLL/SLL

Top 10 research priorities to help people live better with and beyond cancer.

People recently diagnosed with mycosis fungoides and Sézary syndrome may be able to join study

Initial clinical trial results shows this could be a potential treatment.

Scientists whose work underpins a targeted treatment for lymphoma win Nobel Prize for Medicine.

The RATHL Trial and the need to establish the impact of different chemotherapies on fertility.

Education and Training Manager Helen Mee reflects on the first of a series of conferences for people with lymphoma

Your insight could support a NICE assessment for brentuximab vedotin

Dr Becky Salisbury, our Senior Medical Writer, blogs about one of the hot topics from the recent British Society of Haematology meeting.